gsk

Welcome to the 'gsk' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'gsk'.

Latest blogosphere posts tagged “gsk”

• Cytokinetics ends cancer deal with GlaxoSmithKline

  
  HealthPoint PA — Authority: 140
  Philadelphia Inq reports: NEW YORK - Cytokinetics Inc. said Wednesday it ended a deal with GlaxoSmithKline PLC that had focused on developing a potential cancer treatment, sending shares sharply lower in after-hours trading. Cytokinetics said, effective Feb. 28, all rights for the potential cancer treatment ...
  6 hours ago

• Promising new developments on the breast cancer front

  
  DailyFinance — Authority: 777
  Filed under: Company News , Technology , Healthcare , Sanofi Aventis , GlaxoSmithKline The San Antonio Breast Cancer Symposium , held Dec. 9-13, brought mostly good news for breast cancer patients and drugmakers. And thats a welcome development: Aside from non-melanoma skin cancer, breast cancer is the most ...
  23 hours ago

• ($GSK) GlaxoSmithKline Invests in Patch Vaccines

  
  Stock Blog Hub — Authority: 458
  GlaxoSmithKline ( GSK ) recently entered into a strategic alliance with Intercell (INRLF.PK) for the development and commercialization of innovative needle-free patch-based vaccines. The deal includes a vaccine which is being developed by Intercell for travelers’ diarrhea (TD) and also covers an investigational ...
  1 day ago

• Making and Breaking Biotech Deals

  
  SeekingAlpha.com: Home Page — Authority: 644
  The Burrill Report submits: by MARIE DAGHLIAN Celgene ( CELG ) beefed up its blood cancer pipeline with the acquisition of privately-held Gloucester Pharmaceuticals for $340 million in cash plus $300 million in future U.S. and international regulatory milestone payments. Gloucester’s cancer treatment Istodax ...
  1 day ago

• Biotechs Latest Failed Trials, Missed Targets

  
  SeekingAlpha.com: Home Page — Authority: 644
  The Burrill Report submits: Cytokinetics ( CYTK ) and GlaxoSmithKline ( GSK ) agreed to terminate their eight-year collaboration and license agreement on cancer drugs. The termination is effective February 28, 2010. As a result, all rights for GSK-923295, an inhibitor of centromere-associated protein E (CENP-E), ...
  1 day ago

• Roche-ImmunoGen to Start T-DM1 Trials

  
  TheStreet.com — Authority: 468
  The breast cancer drug shrinks tumors and could one day replace Roches blockbuster Herceptin.
  1 day ago

• You can profit from James Altuchers insanity

  
  BloggingStocks — Authority: 676
  Filed under: Newspapers , Interviews , Columns , Books , Entrepreneurs James Altucher is a financial journalist for The Wall Street Journal and founder of Stockpickr.com. His articles cover every angle of the market; he also stars in feature videos with other financial luminaries. He is the author of Trade ...
  3 days ago

• GlaxoSmithKline Study Results Promising for Advanced Breast Cancer Patients

  
  FOXNews.com — Authority: 932
  GlaxoSmithKline announced results of a study at a symposium in San Antonio that showed positive results for an experimental combination therapy for advanced breast cancer patients.
  3 days ago

• Avandia – years of benefits

  
  AdPharm Blog — Authority: 149
  Unlike traditional therapies, Avandia targets the underlying causes of type 2 diabetes – insulin resistance and associated beta-cell failure giving your type 2 diabetes patients sustained glycemic control, and more to feel good about Sustained glycemic control/Years of benefits. Click here to see the details ...
  4 days ago

• Glaxo-Intercell Deal Could Bring New Developments to Vaccine Market

  
  SeekingAlpha.com: Home Page — Authority: 644
  EP Vantage submits: GlaxoSmithKline ( GSK ) signaled its ongoing strong interest in the vaccines space Friday by announcing a deal with Intercell ( INRLF.PK ), over the Austrian company’s portfolio of products delivered through a skin patch. The lead candidate is in phase III trials for travellers’ diarrhoea. ...
  4 days ago

• Synta Pharmaceuticals: Stay Away from This Hopeless Pharma Stock

  
  Penny Sleuth — Authority: 122
  Investors are understandably eyeing pharmaceutical stocks right now – the pharma industry has returned an average of 5 times more than the S&P 500 in the last quarter. And some of the biggest growth has been in the small-cap space. But while most investors clamor to snatch up shares of drug makers, one pharma ...
  4 days ago

• Nicorette – open letter

  
  AdPharm Blog — Authority: 149
  Dear smokers, 2010 is going to suck. Click here to see the details and full-size version in the gallery This ad and thousands more can be seen on the AdPharm gallery , the largest online pharmaceutical advertising gallery.
  6 days ago

• Nicorette – driving tv commercial

  
  AdPharm Blog — Authority: 149
  Click here to see view the commercial. This ad and thousands more can be seen on the AdPharm gallery , the largest online pharmaceutical advertising gallery.
  6 days ago

• (SNTS) Santarus FDA Approvals are on a Roll

  
  Stock Blog Hub — Authority: 458
  With two back-to-back U.S. Food and Drug Administration (FDA) approvals in its kitty, Santarus Inc. ( SNTS ) is on a roll. The company recently received approval for its over-the-counter (OTC) as well as tablet versions of flagship product, Zegerid. Zegerid is Santarus’ lead product which accounted for ...
  1 week ago

• Pharma firms to conduct H1N1 vaccine human trials in India

  
  Thaindian News — Authority: 724
  By Prashant K. NandaNew Delhi, Dec 8 (IANS) An indigenous swine flu vaccine is far from ready but India has given the green signal to two foreign pharmaceutical giants to begin human trials of their vaccine in the country.“GlaxoSmithKline (GSK) and Baxter have received approval from the drug controller of India to ...
  1 week ago

• Could Glaxco Smith Kline crater under one drug - AZT- ? (GSK, rated SELL)

  
  SocialPicks.com: Front Page Picks — Authority: 127
  Is it possiable that one deadly drug could take down an entire company? This movie could be the start and the end! house of numbers http://www.youtube.com/watch?v=X_N4zgjF0K0 AZT is a cytotoxic chemical, a "DNA chain terminator." It interferes with DNA replication, by ...
  1 week ago

• Global Pharmaceutical Industry Boosted by Rising Drug Approvals and Sales in Q3

  
  SeekingAlpha.com: Home Page — Authority: 644
  Research Recap submits: Fitch Ratings says U.S. Food & Drug Administration (FDA) approvals of pharmaceuticals and vaccines have ramped up throughout the year, bringing the year’s total on par with that for all of 2008. FDA drug approvals are on pace to exceed the 2008 total, a second consecutive year of ...
  1 week ago

• Open Innovators Outperform the Market by 16.9%

  
  I'm Not Actually a Geek — Authority: 530
  At the Open Innovation Summit last week in Orlando, there were a number of companies there discussing their various initiatives for open innovation. What is open innovation? UC Berkeley professor Henry Chesbrough, perhaps the father of the movement, formulated this definition several years ago: Open innovation is ...
  1 week ago

• (SNTS) Santarus Gets FDA Approval Boost

  
  Stock Blog Hub — Authority: 458
  Santarus Inc. ( SNTS ) recently received good news with the U.S. Food and Drug Administration (FDA) approving its over-the-counter (OTC) version of Zegerid for the treatment of frequent heartburn. Santarus shares gained more than 16% on the news. The OTC version has been developed under the company’s agreement ...
  1 week ago

• (BAX) Baxter International Gets H1N1 Vaccine Order

  
  Stock Blog Hub — Authority: 458
  Baxter International Inc. ( BAX ) recently received another order for 10,000 H1N1 vaccines, commonly known as “swine flu,” from Slovenia. The order is worth $158,700 (105,000 euros). It is estimated that the number of vaccines ordered is sufficient to cover 5,000 people in the country. Slovenia has also decided ...
  1 week ago

Comments about gsk